{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:59:22Z","timestamp":1792166362571,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":2514,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1186\/s13613-019-0501-3","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T08:04:10Z","timestamp":1549440250000},"page":"27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis"],"prefix":"10.1016","volume":"9","author":[{"given":"Jie","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9163-4396","authenticated-orcid":false,"given":"Genglong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1186\/s13613-019-0501-3_bb0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.chest.2016.07.010","article-title":"Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data","volume":"151","author":"Kadri","year":"2017","journal-title":"Chest"},{"issue":"12","key":"10.1186\/s13613-019-0501-3_bb0015","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1097\/CCM.0b013e31829eb98f","article-title":"Sepsis and scientific revolutions","volume":"41","author":"Artenstein","year":"2013","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1186\/s13613-019-0501-3_bb0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1186\/s13613-019-0501-3_bb0025","doi-asserted-by":"crossref","first-page":"R237","DOI":"10.1186\/cc9392","article-title":"Genome-wide transcription profiling of human sepsis: a systematic review","volume":"14","author":"Tang","year":"2010","journal-title":"Crit Care"},{"issue":"2","key":"10.1186\/s13613-019-0501-3_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1684\/ecn.2011.0281","article-title":"Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock","volume":"22","author":"Tamayo","year":"2011","journal-title":"Eur Cytokine Netw"},{"issue":"12","key":"10.1186\/s13613-019-0501-3_bb0035","first-page":"2693","article-title":"Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study","volume":"35","author":"Werdan","year":"2007","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1186\/s13613-019-0501-3_bb0040","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1186\/s13613-019-0501-3_bb0045","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s00134-014-3474-6","article-title":"Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock","volume":"40","author":"Cavazzuti","year":"2014","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1186\/s13613-019-0501-3_bb0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.cmi.2016.01.021","article-title":"Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins","volume":"22","author":"Giamarellos-Bourboulis","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1186\/s13613-019-0501-3_bb0055","first-page":"Cd001090","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","volume":"16","author":"Alejandria","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1186\/s13613-019-0501-3_bb0060","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1186\/s13613-019-0501-3_bb0065","doi-asserted-by":"crossref","first-page":"R213","DOI":"10.1186\/cc13028","article-title":"Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and\/or myopathy in patients with multiple organ failure and SIRS\/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial","volume":"17","author":"Brunner","year":"2013","journal-title":"Crit Care"},{"issue":"4","key":"10.1186\/s13613-019-0501-3_bb0070","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00540-012-1553-9","article-title":"Effects of IgM-enriched immunoglobulin therapy in septic-shock-induced multiple organ failure: pilot study","volume":"27","author":"Toth","year":"2013","journal-title":"J Anesth"},{"issue":"4","key":"10.1186\/s13613-019-0501-3_bb0075","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","article-title":"Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)","volume":"44","author":"Welte","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1186\/s13613-019-0501-3_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/2046-4053-2-78","article-title":"Methodological developments in searching for studies for systematic reviews: past, present and future?","volume":"2","author":"Lefebvre","year":"2013","journal-title":"Syst Rev"},{"key":"10.1186\/s13613-019-0501-3_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1186\/s13613-019-0501-3_bb0090","unstructured":"Thorlund K EJ, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA). In Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark; 2011: p. 1 \u2013115. www.ctu.dk\/tsa."},{"key":"10.1186\/s13613-019-0501-3_bb0095","first-page":"129","article-title":"Endotoxin concentrations and therapy with polyclonal IgM -enriched immunoglobulins in neutropenic cancer patients with sepsis syndrome: pilot study and interim analysis of a randomized trial","volume":"13","author":"Behre","year":"1995","journal-title":"Anti Infect Drugs chemother"},{"issue":"4","key":"10.1186\/s13613-019-0501-3_bb0100","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.jvca.2005.05.003","article-title":"Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery","volume":"19","author":"Buda","year":"2005","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"10.1186\/s13613-019-0501-3_bb0105","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.CCM.0000215452.84291.C6","article-title":"IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial","volume":"34","author":"Hentrich","year":"2006","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1186\/s13613-019-0501-3_bb0110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01711930","article-title":"Effect of adjuvant immunoglobulin therapy on infections in patients in an surgical intensive care unit. Results of a randomized controlled study","volume":"64","author":"Just","year":"1986","journal-title":"Klinische Wochenschrift"},{"issue":"6","key":"10.1186\/s13613-019-0501-3_bb0115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/cc1837","article-title":"The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view","volume":"6","author":"Karatzas","year":"2002","journal-title":"Crit Care"},{"key":"10.1186\/s13613-019-0501-3_bb0120","first-page":"15","article-title":"Markers of inflammation for prognosis and therapy control in patients with abdominal sepsis\u2014options for using adjuvant intravenous immunoglobulins","author":"Reith","year":"2001"},{"key":"10.1186\/s13613-019-0501-3_bb0125","first-page":"11","article-title":"Immunoglobulina polivalente enel tratamiento de la sepsis abdominal","volume":"18","author":"Rodr\u00edguez","year":"2001","journal-title":"Med Intensiva"},{"issue":"4","key":"10.1186\/s13613-019-0501-3_bb0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.shk.0000157302.69125.f8","article-title":"Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery","volume":"23","author":"Rodriguez","year":"2005","journal-title":"Shock (Augusta, Ga)"},{"issue":"9","key":"10.1186\/s13613-019-0501-3_bb0135","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00003246-199109000-00003","article-title":"Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial","volume":"19","author":"Schedel","year":"1991","journal-title":"Crit Care Med"},{"key":"10.1186\/s13613-019-0501-3_bb0140","first-page":"314","article-title":"auswirkungen von immunglobulinsubstitution bei sepsis","volume":"6","author":"Spannbrucker","year":"1987","journal-title":"Intensivmedizin"},{"issue":"4","key":"10.1186\/s13613-019-0501-3_bb0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/cc1523","article-title":"The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis [ISRCTN28863830]","volume":"6","author":"Tugrul","year":"2002","journal-title":"Crit Care"},{"key":"10.1186\/s13613-019-0501-3_bb0150","doi-asserted-by":"crossref","unstructured":"Vogel F. Bewertung der intraven\u00f6sen IgM-Therapie bei schweren nosokomialen Infektionen (Ergebnis einer kontrollierten randomisierten Studie). Klinisch angewandte Immunologie. Berlin, Heidelberg; 1988. p. 30\u201341.","DOI":"10.1007\/978-3-642-73415-1_3"},{"key":"10.1186\/s13613-019-0501-3_bb0155","first-page":"213","article-title":"Immunoglobulin therapy of postoperative sepsis","volume":"23","author":"Wesoly","year":"1990","journal-title":"Z Exp Chir Transplant Kunstliche Organe"},{"issue":"3","key":"10.1186\/s13613-019-0501-3_bb0160","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1177\/147323001204000337","article-title":"The effects of adjuvant immunoglobulin M-enriched immunoglobulin therapy on mortality rate and renal function in sepsis-induced multiple organ dysfunction syndrome: retrospective analysis of intensive care unit patients","volume":"40","author":"Yavuz","year":"2012","journal-title":"J Int Med Res"},{"issue":"3","key":"10.1186\/s13613-019-0501-3_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jcrc.2005.03.003","article-title":"Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock","volume":"20","author":"Neilson","year":"2005","journal-title":"J Crit Care"},{"issue":"6","key":"10.1186\/s13613-019-0501-3_bb0170","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2796.2006.01726.x","article-title":"Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis","volume":"260","author":"Norrby-Teglund","year":"2006","journal-title":"J Intern Med"},{"issue":"12","key":"10.1186\/s13613-019-0501-3_bb0175","first-page":"2686","article-title":"Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis","volume":"35","author":"Laupland","year":"2007","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1186\/s13613-019-0501-3_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16070","volume":"16","author":"Soares","year":"2012","journal-title":"Health Technol Assess"},{"issue":"5","key":"10.1186\/s13613-019-0501-3_bb0185","first-page":"559","article-title":"Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness","volume":"82","author":"Busani","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"10.1186\/s13613-019-0501-3_bb0190","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcrc.2018.06.005","article-title":"The use of IgM-enriched immunoglobulin in adult patients with sepsis","volume":"47","author":"Kakoullis","year":"2018","journal-title":"J Crit Care"},{"issue":"15","key":"10.1186\/s13613-019-0501-3_bb0195","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"New Engl J Med"},{"issue":"1","key":"10.1186\/s13613-019-0501-3_bb0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13613-017-0268-3","article-title":"The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure","volume":"7","author":"Martin-Loeches","year":"2017","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1186\/s13613-019-0501-3_bb0205","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4037\/ajcc2006.15.5.502","article-title":"Factors influencing length of stay in the intensive care unit","volume":"15","author":"Gruenberg","year":"2006","journal-title":"Am J Crit Care"},{"issue":"4","key":"10.1186\/s13613-019-0501-3_bb0210","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/joim.12265","article-title":"Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis","volume":"276","author":"Bermejo-Martin","year":"2014","journal-title":"J Intern Med"},{"key":"10.1186\/s13613-019-0501-3_bb0215","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13054-015-0793-0","article-title":"The original sins of clinical trials with intravenous immunoglobulins in sepsis","volume":"19","author":"Almansa","year":"2015","journal-title":"Crit Care"},{"issue":"4","key":"10.1186\/s13613-019-0501-3_bb0220","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/SHK.0b013e3181a2c0b2","article-title":"Gamma-globulin levels in patients with community-acquired septic shock","volume":"32","author":"Taccone","year":"2009","journal-title":"Shock (Augusta, Ga)"},{"issue":"3","key":"10.1186\/s13613-019-0501-3_bb0225","first-page":"157","article-title":"Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy","volume":"11","author":"Ahsan","year":"1998","journal-title":"J Nephrol"},{"issue":"12","key":"10.1186\/s13613-019-0501-3_bb0230","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1345\/aph.1E040","article-title":"Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation","volume":"38","author":"Chapman","year":"2004","journal-title":"Ann Pharmacother"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13613-019-0501-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-019-0501-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025009239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582025009239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-019-0501-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:32:18Z","timestamp":1776670338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582025009239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["S2110582025009239"],"URL":"https:\/\/doi.org\/10.1186\/s13613-019-0501-3","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s13613-019-0501-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 The Author(s) 2019. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}],"article-number":"27"}}